Uji klinis Epilepsi di Alabama
9 studi untuk Epilepsi mencari peserta di lokasi di Alabama.
Kota di Alabama
Teks studi resmi (Bahasa Inggris)
Diagnosing Epilepsy To EffeCT Change
- UAB Epilepsy Center, Birmingham
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07110337Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- UAB Epilepsy Center, Birmingham
Menerima pesertaStudi observasional
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07110454Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Clinic for Neurology, Huntsville
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07594119AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
- University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 1/2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT06063850A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- University of Alabama - Strada Patient Care Center, Neurology, Mobile
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT05667142Stimulation-Induced Changes in Fronto-Limbic Network
- Epilepsy Monitoring Unit UAB Hospital, Birmingham
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT05854160Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Alabama, Birmingham
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT05135091Investigating Dynamic Interactions in Distributed Cognitive Control Networks
- University of Alabama at Birmingham, Birmingham
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT05927974Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
- University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2
1 Day – 6 Months · Semua jenis kelamin · Diperbarui 22 Jan 2026 · NCT05104983Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.